Citi Pharma Limited (PSX: CPHL)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
93.66
+8.07 (9.43%)
At close: Jan 28, 2025
324.76%
Market Cap 21.40B
Revenue (ttm) 12.93B
Net Income (ttm) 940.51M
Shares Out 228.46M
EPS (ttm) 4.12
PE Ratio 22.72
Forward PE n/a
Dividend 3.25 (3.80%)
Ex-Dividend Date Oct 17, 2024
Volume 26,038,100
Average Volume 11,876,188
Open 85.10
Previous Close 85.59
Day's Range 83.01 - 94.15
52-Week Range 20.01 - 96.38
Beta 0.52
RSI 71.38
Earnings Date Feb 28, 2025

About Citi Pharma

Citi Pharma Limited engages in the manufacture and sale of pharmaceutical, medical chemical, and botanical products in Pakistan. Citi Pharma Limited was incorporated in 2012 and is headquartered in Lahore, Pakistan. [Read more]

Industry Pharmaceuticals
Sector Healthcare
Founded 2012
Employees 519
Stock Exchange Pakistan Stock Exchange
Ticker Symbol CPHL
Full Company Profile

Financial Performance

In 2024, Citi Pharma's revenue was 12.41 billion, an increase of 0.10% compared to the previous year's 12.40 billion. Earnings were 833.46 million, an increase of 26.67%.

Financial Statements

News

There is no news available yet.